Journal of Chemotherapy · 2020 · 14 citations · 41 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacologyAntimicrobial ResistanceBacteriologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsCarbapenem ResistanceEfflux-mediated ResistanceResistance GenesAcinetobacter Baumannii ResistanceAntibiotic Resistance GenesBacterial Efflux PumpsColistin Resistance MechanismsDrug Efflux PumpsEfflux Pump GenesEfflux Pump MutationsMultidrug Efflux Pumps
Colistin resistant Acinetobacter baumannii strains are of great concern worldwide. However, the role of efflux pumps in colistin resistance needs to be elucidated. We investigated the changes in colistin MICs of 29 colistin resistant A. baumannii isolates in response to resistance-nodulation-division (RND)-type efflux pump inhibitor (EPI) and the alterations in AdeR and AdeS two-component regulatory proteins previously associated with the overproduction of AdeAB. The EPI, 1-(1-naphthylmethyl)-piperazine (NMP), led to significant reductions in colistin MICs. At least one of the following amino acid substitutions was found in AdeS proteins from 18 of the isolates: L172P, A94V, V27I, V32I, G186V, and G164A. Besides, A136V and V120I alterations were identified in AdeR from five isolates. Therefore, EPI-responsive colistin resistance in our isolates is most likely due to the action of an RND-type efflux system. The underlying mechanism of resistance might be the result of certain AdeRS alterations, leading to AdeAB overexpression.
41
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
Dawn Sievert, Philip Ricks, Jonathan R. Edwards et al. · Infection Control and Hospital Epidemiology · 2012 · 1.6K citations
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
Olga Lomovskaya, Mark S. Warren, Angela Lee et al. · Antimicrobial Agents and Chemotherapy · 2001 · 889 citations · Full text